Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETXP) Cash & Equivalents (2016 - 2025)

Cemtrex filings provide 16 years of Cash & Equivalents readings, the most recent being $21.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 415.67% to $21.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.8 million, a 415.67% increase, with the full-year FY2025 number at $6.3 million, up 17.1% from a year prior.
  • Cash & Equivalents hit $21.8 million in Q4 2025 for Cemtrex, up from $6.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $21.8 million in Q4 2025 to a low of $2.9 million in Q1 2024.
  • Median Cash & Equivalents over the past 5 years was $6.8 million (2023), compared with a mean of $8.8 million.
  • Biggest five-year swings in Cash & Equivalents: soared 874.66% in 2021 and later tumbled 56.04% in 2024.
  • Cemtrex's Cash & Equivalents stood at $10.3 million in 2021, then tumbled by 44.21% to $5.8 million in 2022, then plummeted by 30.37% to $4.0 million in 2023, then increased by 5.16% to $4.2 million in 2024, then surged by 415.67% to $21.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $21.8 million (Q4 2025), $6.3 million (Q3 2025), and $7.0 million (Q2 2025) per Business Quant data.